Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance
Top Cited Papers
Open Access
- 1 January 2008
- journal article
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- Vol. 10 (1) , 42
- https://doi.org/10.1186/1532-429x-10-42
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunctionJournal of Cardiovascular Magnetic Resonance, 2008
- Multi-center transferability of a breath-hold T2 technique for myocardial iron assessmentJournal of Cardiovascular Magnetic Resonance, 2008
- Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosisBlood, 2006
- Development of Thalassaemic Iron Overload Cardiomyopathy despite Low Liver Iron Levels and Meticulous Compliance to DesferrioxamineActa Haematologica, 2006
- Intercentre Reproducibility of Magnetic Resonance T2* Measurements of Myocardial Iron in ThalassaemiaThe International Journal of Cardiovascular Imaging, 2005
- Deferiprone therapy for transfusional iron overloadBest Practice & Research Clinical Haematology, 2005
- Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia majorBlood, 2004
- Severe Bacterial Infection in Transfusion-Dependent Patients with Thalassemia MajorClinical Infectious Diseases, 2003
- Comparison of the Effects of Deferiprone versus Deferoxamine on Growth and Virulence of Yersinia enterocoliticaAntimicrobial Agents and Chemotherapy, 2002
- Survival in β-thalassaemia major in the UK: data from the UK Thalassaemia RegisterThe Lancet, 2000